Professor of Health Services and Medicine
UCLA School of Public Health
Department of Health Services
Box 951772
Los Angeles, CA 90095-1772
(310) 206-1404
Fax: (310) 206-3566
E-mail: pganz@ucla.edu

Patricia Ganz is Professor of Health Services in the School of Public Health, Professor of Medicine in the David Geffen School of Medicine at UCLA, and Vice Chair of the Department of Health Services. She teaches Health Care Practices and Variations and Ethical Issues in Public Health. Dr. Ganz received her M.D. from the University of California, Los Angeles, School of Medicine in 1973, and completed post-doctoral training in internal medicine and medical oncology at the UCLA Medical Center. She has been on the faculty of the School of Medicine since 1977, and joined the faculty of the School of Public Health in 1992. Dr. Ganz has devoted the past 25 years to the study of quality-of-life outcomes in cancer and other chronic diseases. She is a leader in the integration of quality-of-life assessment in clinical trials. She has conducted federally funded research for over two decades, and has led several large clinical intervention trials in breast cancer. Her current research focuses on the late effects of cancer treatment, and improving the quality of care for cancer survivors. In 2006, she received funding from the Lance Armstrong Foundation to establish the UCLA-LIVESTRONG Survivorship Center of Excellence, whose mission is to facilitate improvements in the quality of life and quality of care of cancer survivors in the Los Angeles region and wherever they may reside.
Dr. Ganz is also the Director of the Division of Cancer Prevention and Control Research of the Jonsson Comprehensive Cancer Center at UCLA, and leads a large research group that applies the scientific disciplines of public health (epidemiology, health services, behavioral sciences, biostatistics) to research on the prevention, detection, treatment and supportive care of cancer. Dr. Ganz is Associate Editor of the Journal of Clinical Oncology, the Journal of the National Cancer Institute and is a member of the editorial board of the Cochrane Breast Cancer Group. In 1999 she was named an American Cancer Society Clinical Research Professor and in 2007 she became a member of the Institute of Medicine.

Selected Publications

Kahn, K.L., Malin, J. L., Adams, J., Ganz, P.A.: Developing a Reliable, Valid, and Feasible Plan for Quality-of-Care Measurement for Cancer: How Should We Measure? Medical Care 40:73-85, 2002.

Ganz, P.A., Farmer, M.M., Belman, M., Malin, J.L., Bastani, R., Kahn, K.L., Dietrich, A., Fielding, J.: Improving Colorectal Cancer Screening Rates in a Managed Care Health Plan: Recruitment of Provider Organizations for a Randomized Effectiveness Trial. Cancer Epidemiology Biomarkers & Prevention 12:824-829, 2003.

Ganz, P.A., Kwan, L., Stanton, A. L., Krupnick, J.L., Rowland, J.H., Meyerowitz, B.E., Bower, J.E., Belin, T.R.: Quality of Life at the End of Primary Treatment of Breast Cancer: first results from the Moving Beyond Cancer randomized trial. Journal of the National Cancer Institute 96:376-87, 2004.

Castellon, S.A., Ganz, P.A., Bower, J.E., Petersen, L., Abraham, L., Greendale, G.A.: Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen. Journal of Clinical and Experimental Neuropsychology 26:955-969, 2004.

Bower, J.E., Ganz, P.A., Aziz, N., Fahey, J.L.: Altered Cortisol Response to Psychological Stress in Breast Cancer Survivors with Persistent Fatigue. Psychosomatic Medicine 67(2):277-80, 2005.

Bower, J.E., Meyerowitz, B.E., Desmond, K.A., Bernaards, C.A., Leedham, B., Rowland, J.H., Ganz, P.A.: Perceptions of positive meaning and vulnerability following breast cancer: Predictors and outcomes among long-term breast cancer survivors. Annals of Behavioral Medicine, 29(3):236-45, 2005.

Stanton, A.L., Ganz, P.A., Kwan, L., Meyerowitz, B.E., Bower, J.E., Krupnick, J.L., Rowland, J.H., Belin, T.R.: Outcomes from the Moving Beyond Cancer Psychoeducational Randomized, Controlled Trial with Breast Cancer Patients. Journal of Clinical Oncology 23:6009-6018, 2005.

Ganz, P.A., Farmer, M.M., Belman, M., Garcia, C.A., Streja, L., Dietrich, A.J., Winchell, C., Bastani, R., Kahn, K.L.: Results of a Randomized Controlled Trial to Increase Colorectal Cancer Screening in a Managed Care Health Plan. Cancer 104:2072-83, 2005.

Land SR, Wickerham DL, Costantino JP, Ritter MW, Vogel VG, Lee M, Pajon ER, Wade JL 3rd, Dakhil S, Lockhart JB Jr, Wolmark N, Ganz PA. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006 Jun 21;295(23):2742-51. Epub 2006 Jun 5.

Silverman, D.H.S., Dy, C.J., Castellon, S.A., Lai, J., Pio, B.S., Abraham, L., Waddell, K., Petersen, L., Phelps, M.E., Ganz, P.A.: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5 to 10 years after chemotherapy. Breast Cancer Res Treat. Epub 2006 September 29.

Ganz, P.A. Monitoring the Physical Health of Cancer Survivors: A Survivorship-Focused Medical History. J Clin Oncol 24:5105-5111, 2006.

Ganz, P.A., & Goodwin, P.J.: Health-Related Quality of Life measurement in Symptom Management Trials. J Natl Cancer Inst Monogr. 37:47-52, 2007

Ganz, P.A., Gotay, C.C.: Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions. Journal of clinical oncology. 25(32):5063-9, 2007.